10
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Literature Alerts

Pages 529-540 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • %99m-Technetium-stannous oxinate as marker of liposome formulations. ALAFANDY, M., GOFFINET, G., UMBRAIN, V. D., HAESE, J., CAMU, F., and LEGROS, F. J., Nucl. Med. Biol., 1996, 23 (7), 881–887.
  • A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. WILLIAMS, A. S., CAMILLERI, J. P., GOODFELLOW, R. M., and WILLIAMS, B. D., Br. y. Rheumatol., 1996, 35 (8), 719–724.
  • A clinical trial: in vivo studies on dexamethasone sodium phosphate liposomes in the treatment of human aphthous stomatitis. FARSHI, F. S., OZER, A. Y., TAVASSOLI, S., SUNGUR, A., and HINCAL, A. A.,.7. Liposome Res., 1996, 6 (4), 699–712.
  • A method to detect leakage of DNA intercalators through liposome membranes. SILVANDER, M., and EDWARDS, K., Anal. Biochem., 1996, 242 (1), 40–44.
  • A monitoring system for energy transduction by bacteriorhodopsin lipsomes. HENDLER, R. W., MUKHOPADHYAY, A. K., SMITH, P. D., and CASCIO, H. E.,.7. Biochem. Biophys. Methods, 1996, 33 (2), 89–104.
  • A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. STEPHEN, D. J., YANG, Z. Y., SAN, H., SIMARI, R. D., WHEELER, C. J., FELGNER, P. L., GORDON, D., NABEL, G. J., and NABEL, E. G., Hum. Gene. Ther., 1996, 7 (15), 1803–1812.
  • A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. ZHU, J., ZHANG, L., HANISCH, U. K., FELGNER, P. L., and RESZKA, R., Gene. Ther., 1996, 3 (6), 472–476.
  • A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. ALAK, A., MOY, S., and BEKERSKY, I., Ther. Drug Monit., 1996, 18 (5), 604–609.
  • A replication-deficient adenovirus enhances liposome-mediated nucleic acid transfer into a stable cell line expressing Ti RNA polymerase. HONDA, M., Hu, P. C., HUANG, C. H., MATSUI, H., and LEMON, S. M.,Virol. Methods, 1996, 58 (1-2), 41–51.
  • Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. OLIVA, G., GRADONI, L., CIARAMELLA, P., DE LUNA, R., CORTESE, L., ORSINI, RSINI., DAVIDSON, R. N., and PERSECHINO,Antimicrob. Chemother., 1995, 36 (6), 1013-1019.Adsorption and Chromatography properties of Styrosorb-type microspherical polymer sorbents. BELYAKOVA, L. D., VASILEVSKAYA, 0. B., TSYURUPA, M. P., and DAVENKOV, V. A., Zh. Fiz. Khim., 1996, 70 (8), 1476–1481.
  • Alcohol-induced formation of interdigitated gel structure in liposomal membrane. KOMATSU, H. Maku, 1996, 21 (5), 311–317.
  • Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. SUNTRES, Z., and SHEK, P. N., Biochem. Pharmacol., 1996, 52 (10), 1515–1520.
  • An evaluation of microencapsulated PCM for use in cold energy transportation medium. YAMAGISHI, Y., SUGENO, T., ISHIGE, T., TAKEUCHI, H., and PYATENKO, A. T., PTOC. Intersoc. Energy Conyers. Eng. Conf., 1996, 31, 2077–2083.
  • Antigens linked to synthetic microspheres induce immune responses in primates in the —absence of adjuvant. SEDLIK, C., PERRAUT, R., BoNNEmAiNs, B., and LECLERC, C., Immuno-biology, 1996, 195 (1), 105–118.
  • Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labeled vesicles. FRESTA, M., and PucLisi, G., .7. Drug Targeting, 1996, 4 (2), 95–101.
  • Application of long-circulating liposomes containing amphipathic polyethylene glycol for sustained releasable carriers. Yurm, T., MARUYAMA, K., KOJIMA, S., and 1Nya-rawly, M., Yakuzaigaku, 1996, 56 (2), 78–84.
  • Association between capsule diameter, adequacy of encapsulation, and survival of micro-encapsulated rat islet allografts. DE VOS, P., DE HAAN, B., PATER, J., and VAN SCHILFGAARDE, R., Transplantation, 1996, 62 (7), 893–899.
  • Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescene after oral and parenteral administration to male Wistar rats. JANT, P. U., NOMURA, T., YAMASHITA, F., TAICAKURA, Y., FLORENCE, A. T., and HASHIDA, M., y. Drug Targeting, 1996, 4 (2), 87–93.
  • Binding composition with micropheres from coal ash wastes. KOUGIYA, M. V., and SAMUSEVA, M. N., Tsement, 1996, (3), 28–31.
  • Binding of daidzein to liposomes. LEHTONEN, J. Y. A., ADLERCREITFZ, H., and KINNUNEN, P. K. J Biochim. Biophys. Acta, 1996, 1285 (1), 91–100.
  • Bioadhesive liposomes for topical treatment of wounds. MARGALIT, R., Drugs Pharm. Sci., 1996, 77, 425–461.
  • Biodegradable gelatin microspheres for drug delivery to macrophages. TABATA, Y., and IICADA, Y., Drugs Pharm. Sci., 1996, 77, 401–423.
  • Biodistribution and CT-imaging characteristics of iopromide-carrying liposomes in rats. LEIKE, EIKE., SACHSE, A., Emurr, C., and Krause, W., J. Liposome Res., 1996, 6 (4), 665-680. Biodistribution of surface-modified liposomes and particles. TORCHILIN, V. P., TRUBETSKOY, V. S., Drugs Phartn. Sc., 1996, 77, 243–277.
  • Biological and physicochemical properties of fenitrothion microcapsules as a residual spraying formulation for mosquito control. KAWADA, H., OGAWA, M., ITOH, T., and ABE, Y., J. Am. Mosq. Control. Assoc., 1995, 11 (4), 441–447.
  • Calcium-antagonists, a comparative study on isolated guinea pig atria and on liposomes. TAWK, S. HODA., Bull. Foe. Pharm. (Cairo Univ), 1996, 34 (1), 21–26.
  • Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. CHENG, H. Y., RANDALL, C. S., HOLL, W. W., CONSTANI1NIDES, P. P., YUE, T. L., and FEUERSTEIN, G. Z., Biochim. Biophys. Acta, 1996, 1284 (1), 20–218.
  • Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial disease. YONEMITSU, Y., KANEDA, Y., MORISHITA, R., NAKAGAWA, K., NAICASHIMA, Y., and SUEISHI, K., Lab. Invest., 1996, 75 (3), 313–323.
  • Characterization of PLGA microspheres for the controlled delivery of IL-1 alpha for tumor immunotherapy. CHEN, L., Arm, R. N., and COHEN, S., y. Controlled Release, 1997, 43 (2, 3), 261–272.
  • Co-existence of serum-dependent and serum-independent mechanisms for liposome clear-ance and involvement of non-Kupffer cells in liposome uptake by mouse liver. Hu, Q., and Liu, D., Biochim. Biophys. Acta, 1996, 1284 (2), 153–161.
  • Combined modality radioprotection: enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phospha-tidylethanolamine (MTP-PE) and indomethacin. FEDOROCKO, P., and MACKOVA, N. 0., Int. J. Immunopharmacol., 1996, 18 (5), 329–337.
  • Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. DIPALI, S. R., KULICARNI, S. B., BETAGERI, K., and BETAGERI, G. v., J. Pharm. Pharmacol., 1996, 48 (11), 1112–1115.
  • Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-P-cyclodex-trin/drug complexes after intravenous injection into rats: implications in drug delivery. McCozmAcx, B., and GREGORIADIS, G., Biochim. Biophys. Acta, 1996, 1291 (3), 237–244.
  • Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. THAKUR, C. P., FANDEY, A. K., SINICA, G. P., ROY, S., BEHBEHANI, K., OLLIARO, P., Trans. R. Soc. Trop. Med. Hyg., 1996, 90 (3), 319–322.
  • Competitive analysis of ribonuclease interaction with liposomes. GORBENKO, G. P., Ukr. Biokhim. Zh., 1996, 68 (1), 55–60.
  • Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies. SZEBENI, J., WASSEF, N. M., RUDOLPH, A. S., and ALVING, C. R., Biochim. Biophys. Acta, 1996, 1285 (2), 127–130.
  • Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. HAGSTROM, J. E., SEBESTYEN, M. G., BUDKER, V., LUDTKE, J. J., FRITZ, J. D., and WOLF, J. A., Biochim. Biophys. Acta, 1996, 1284 (1), 47–55.
  • Compositional limit of stability of negatively charged liposomes contacting a polycation. YAROSLAVOV, A. A., KISELEVA, E. A., UDALYICH, 0. Y., KABANOV, V. A., Dokl. Akad. Nauk., 1996, 349 (1), 67–69.
  • Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. ELCCIN, Y. M., DIXIT, V., and Grmicx, G., Artif. Cells Blood Substit. Immobil. Biotechnol., 1996, 24 (3), 257–271.
  • Cytotoxicity, stability and antitumor activity of 5-fiuorouracil prodrugs entrapped in liposomes. LEE, G. W., and Jss, U. K., Yakhak Hoechi, 1996, 40(5), 522–531.
  • Dense microspheres in normal horse brain. FURUOKA, H., YAMADA, M., MIYAZAWA, K., TANIYAMA, H., and MATSUI, T., Acta. Neuropathol. (Berl), 1996, 91 (4), 440–443.
  • Determinants of liposome partitioning in aqueous two-phase systems: evaluation by means of a factorial design. MOLDAVSKI, N., and COHEN, S., Biotechnol. Bioeng., 1996, 52 (4), 529–537.
  • Determination of micromertic properties and permeability of flurbiprofen microcapsules prepared by emulsification solvent evaporation technique. RAO, B. S., MURTHY, K. V. R., and FtAo, A. S., East. Pharm., 1996, 39 (463), 131–132.
  • Determination of imazethapyr using capillary column flow injection liposome immunoanalysis. LEE, M., and DURST, R. A., J. Agric. Food Chem., 1996, 44 (12), 4032–4036.
  • Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. SHIMADA, K., MIYAGISHIMA, A., SADZUICA, Y., NOZAWA, Y., MOCHIZUKI, Y., OHSHIMA, H., and HIROTA, S., J. Drug Target., 1995, 3 (4), 283–289.
  • Development of furosemide loaded poly(methyl methacrylate) microspheres. SA, B., and GHOSH, A., Indian Drugs, 1996, 33 (10), 521–524.
  • Direct extraction of A and B blood group antigens from human red cells by liposomes. SUZUKI, K., OKUMURA, Y., SATO, T., YASUDA, T., OKI, A., OKI, M., and SUNAMOTO, J., Transfusion, 1996, 36 (11-12), 966–968.
  • Distribution of zinc tetraphenylprophine in a single melamine resin/toluene microcapsules studies by laser trapping microspectroscopy. KIM, H. B., YOSHIDA, S., MIURA, A., and KITAMURA, N., Chem. Lett., 1996, (11), 923–924.
  • Distribution of etoposide-loaded hydrophilic albumin microspheres in mice. RAVIKUMAR, H. R., DHANARAJ, S. A., RAJENDRAN, D., DUBE, R., and Surma', B., Drug Dev. Ind. Pharm., 1996, 22 (9 & 10), 1005–1008.
  • Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer. ROBERTS, T., DE BONI, U., and SEFTON, M. V., Bio-materials, 1996, 17 (3), 267–275.
  • Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis. CASTAGNOLA, E., DAVIDSON, R. N., FIORO, P., TASSO, L., Rossi, G., MANGRAVITI, S., DI MARTINO, L., Scorn, S., CASCIO, A., PEMPINELLO, R., GRADONI, 0., and GIACCHINO, R., Trans. R. Soc. Trop. Med. Hyg., 1996, 90 (3), 317–318.
  • Effect of negatively charged lipid compositions on the immunomodulating action of cephar-anthine-containing liposomes. SHINODA, K. I., SATO, H., ADACHI, I., and HORIKOSHI, I., Yakuzaigaku, 1996, 56 (3), 163–168.
  • Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. CHANDY, T., and SHARMA, C. P., Biomaterials, 1996, 17 (I), 61–66.
  • Effect of liposome-encapsulation on immunomodulating and antiviral activities of inter-feron-gamma 1. SARAVOLAC, E. G., KOURNIICAKIS, B., GORTON, L., and WONG, J. P., Antiviral. Res., 1996, 29 (2-3), 199–207.
  • Effect of surfactant agents on the in vitro release of insulin from DL-PLA microspheres. SORIANO, I., DELGADO, A., KELLAWAY, I., and EVORA, C., Drug Dev. Ind. Pharm., 1996, 22 (9 & 10), 1009–1012.
  • Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection. TAICEUCHI, K., ISHIHARA, M., KAWAURA, C., NOJI, M., FURUNO, T., and NAKANISHI, M., FEBS Lett., 1996, 397 (2, 3), 207–209.
  • Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. MENET, P., BOISDRON, C. M., CROUE, A., GUY, G., BENOIT, J. P., Neurosurgery, 1996, 39 (1), 117–123; discussion 123–124.
  • Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. ZEISIG, R., SHIMADA, K., HIROTA, S., and ARNDT, D., Biochim. Biophys. Acta, 1996, 1285 (2), 237–245.
  • Effect on glass microspheres on the resistance of an epoxy coating to erosive and abrasive wear. KOTNAROWSKA, D., Tribologia, 1996, 27 (4), 394–402.
  • Effects of liposomal antisense oligonucleotides on mitNA and protein levels of the HPV 16 E7 oncogene. LAPPALAINEN, K., PIRILA, L., JAASKELAINEN, I., SYRJANEN, K., and SYRJANEN, S., Anticancer Res., 1996, 16 (5A), 2485–2492.
  • Effects of selected formulation parameters on the entrapment of diclofenac sodium in ethyl cellulose microspheres. JAm, G.-K., GOHEL, M.-C., J. Controlled Release, 1997, 43 (2, 3), 245–250.
  • Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. KIKUCHI, A., SUGAYA, S., UEDA, H., TANAKA, K., ARAMAKI, Y., HARA, T., ARIMA, H., TSUCHIYA, S., and FUWA, T., Biochem. Biophys. Res. Commun., 1996, 227 (3), 666–671.
  • Electrophoretic behavior of dye-containing liposome in a capillary with original online chemiluminescence detection. TSUKAGOSHI, K., OKUMURA, Y., AKASAKA, H., NAKAJIMA, R., and MARA, T., Anal. Sci., 1996, 12 (6), 869–874.
  • Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation. GOMEZ, F. R., Hsu, R., TArviEz, G. R., and MEFITA, R. T., Antimicrob. Agents Chemother., 1996, 40(11), 2545–2549.
  • Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. TA/CEUCHI, H., YAMAMOTO, H., NIWA, T., Hugo, T., and KAWASHIMA, Y., Pharm. Res., 1996, 13 (6), 896–901.
  • Enzyme therapy of xeroderma pigmentosum: safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. YAROSH, D., KLEIN, J., KnuTEL, J., ALAS, L., 0 CONNOR, A., CUMMINGS, B., GROB, D., GERSTEIN, D., GILCHREST, B. A., et al. Photodermatol., Photoimmunol. Photomed., 1996, 12 (3), 122–130.
  • Enzyme and chemical encapsulation in polymeric microcapsules. PARTHASARATHY, R. V., and MARTIN, C. R., J. Appl. Polym. Sci., 1996, 62 (6), 875–886.
  • Enzymic reactions in liposomes. WALDE, P., Curr. Opin. Colloid. Interface Sci., 1996, 1 (5), 638–644.
  • Europium chelate-loaded lipsomes: a tool for the study of binding and integrity of liposomes. ORELLANA, A., LAUKKANEN, M. L., and KETNANEN, K., Biochim. Biophys. Acta, 1996, 1284 (1), 29–34.
  • Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay. OICADA, N., FUSHIMI, M., NAGATA, Y., FUKUNAGA, T., TSUTSUMI, Y., NAKAGAWA, S., and MAYUMI, T., jpn. J. Cancer Res., 1996, 87 (9), 952–957.
  • Evaluation of liposome loaded with retinoic acid: differential scanning calorimetry analysis, in vitro release and skin permeation. MONTENEGRO, L., Pitmen, A. M., and BONINA, F. P., Acta Technol. Legis. Med., 1995, 6 (3), 232–242.
  • Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model. BRAZEAU, G. A., SCIAME, M., At. SUWAYEH, S. A., and FATTAL, E., Pharm. Dev. Technol., 1996, 1 (3), 279–283.
  • Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method. PAVANETTO, F., PERUGINI, P., CONTI, B., MODENA, T., and GENTA, I., J. Microencapsulation, 1996, 13 (6), 679–688.
  • Evaluation of the effect of microencapsulation and immunomodulation on islet immuno-genicity in vitro. SIEBERS, U., ENDL, U., HORCHER, A., BRETZEL, R. G., FEDERLIN, K., and ZEKORN, T., Exp. Clin. Endocrinol. Diabetes, 195, 103 (suppl 2), 140–142.
  • Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethy-lene glycol acid on peritoneal carcinomatosis in rats. TOKUDA, K., NATSUGOE, S., SHIMADA, HIMADA., KUMANOHOSO, T., YOSHIZAWA, H., UEMURA, Y., HATATE, Y., NAKAMURA, K., YAMADA, K., NEDACHI, M., and Anco, T., Gan. To. Kagaku. Ryoho., 1996, 23 (II), 1516–1518.
  • Expression of full-length human dystrophi'n cDNA in mdx mouse muscle by HVJ-liposome injection. YANAGIHARA, I., INUI, K., DICKSON, G., TURNER, G., PIPER, T., KANEDA, Y., and OKADA, S., Gene. They., 1996, 3 (6), 549–553.
  • Expression of the human multidrug resistance and glucocerebrosidase DNAs from adeno-associated vectors: efficient promoter activity of AAV sequences and in vivo delivery via liposomes. BAUDARD, M., FLorrE, T. R., ARAN, J. M., THIERRY, A. R., PASTAN, I., PANG, M. G., KEARNS, W. G., and GoTTEsmAN, M. M., Hum. Gene. They., 1996, 7(11), 1309–1322.
  • Factors influencing the adequacy of microencapsulation of rat pancreatic islets. DE VOS, P., DE HAAN, B., WOLTERS, G. H., and VAN SCHILFGAARDE, R., Transplantation, 1996, 62 (7), 888–893.
  • Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. ST PIERRE, Y., DESROSIERS, M., TREMBLAY, P., ESTEVE, P. 0., and OPDENAKKER, G., Cytometry, 1996, 25 (4), 374–380.
  • Functional reconstitution of photosystem I reaction center from cyanobacterium Synecho-cystis sp PCC6803 into liposomes using a new reconstitution procedure. CLADERA, J., RmAun, J. L., Borrnst, H., and DUNACH, m., .y. Bioenerg. Biotnembr., 1996, 28 (6), 503–515.
  • Fusigenic viral liposome for gene therapy in cardiovascular disease (comment). DZAU, V. J., MANN, M. J., MORISHITA, R., and KANEDA, Y., Proc. Natl. Acad. Sci. USA, 1996, 93 (21), 11421–11425. 27 Refs.
  • Fusigenic liposome-mediated DNA transfer into cardiac myocytes. ELL:sox, K. E., BISHOPRIC, N. H., WEBSTER, K. A., MORISHITA, R., GIBBONS, G. H., KANEDA, Y., SATO, B., and DZRU, V. J., J. Mol. Cell. Cardiol., 1996, 28 (7), 1385–1399.
  • Gelatin-acacia complex coacervation as a method for ketoprofen microencapsulation. PALMIERI, G. F., MARTELL, S., LAURI, D., and WEHRLE, P., Drug Den. Ind. Pharm., 1996, 22 (9 & 10), 951–957.
  • Generation of streaming potential by liposomes in cylindrical capillary. A physical model. ZAWADA, Z. H., Gen. Physiol. Biophys., 1996, 15 (2), 165–173.
  • Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. CASTILLO, J., CURLEY, J., HOTZ, J., UEZONO, M., TIGNER, J., CHASIN, M., WILDER, R., LANGER, R., and BERDE, C., Anesthesiology, 1966, 85 (5), 1157–1166.
  • Growth retardation-an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. AL HENDY, A., HORTELANO, G., TANNENBAUM, G. S., and CHANG, P. L., Hum. Gene. Ther., 1996, 7 (1), 61–70.
  • Heparin protection against Fe2+- and Cu2+-mediated oxidation of liposomes. ALBERTINI, R., RIND, S., PASS, A., PALLAVICINI, G., and DE LucA, G., FEBS-Lett., 1996, 383 (3), 155–158. Highly fluorinated surfactants in liposome technology. SZOENYI, S., WATZKE, H. J., and CAMBON, A., Thin Solid Films, 1966, pp. 284–285. 769–771.
  • Hollow carbon microspheres and fibers produced by catalytic pyrolysis and observed in shungite rocks. KOVALEVSKI, V. V., SAPHRONOV, A. N., and MARKOVSKI, J. A., Mol. Cryst. Liq. Cryst. Sci. Technol., 1996, 8 (1-2), 21–24.
  • Immobilized liposome chromatography of drugs on capillary continuous beds for model analysis of drug-membrane interactions. ZHANG, Y., ZENG, C. M., LI, Y. M., HJERTEN, S., and LUNDAHL, P., J. Chromatogr., A., 1996, 749 (1+ 2), 13–18.
  • Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. NABEL, G. J., GORDON, D., BISHOP, D. K., NICKHOLOFF, B. J., YANG, Z., ARUGA, A., CAMERON, M. J., NABEL, E. G., and CHANG, A. E., Proc. Natl. Acad. Sci. USA, 1996, 93 (26), 15388–15393.
  • Importance of liposome complexing volume in transfection optimization. STAGGS, D. R., BURTON, D. W., and DEFTOS, L. J., Bio Techniques, 1996, 21(5), 792–798.
  • Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances. GRAMMER, J. B., KORTUM, F. A., WOLBURG, H., LUDTKE, R., SCHMIDT, K. H., THIEL, H. J., and PLEYER, U., Curr. Eyes. Res., 1996, 15 (8), 815–823.
  • Improved coronary vasodilatory function after ischemia-reperfusion by liposomal coenzyme Q10; comparison with other antioxidant agents. YOKOYAMA, H., MOMENI, R., Korr, B. R., CRESTANELLO, J. A., and WHITMAN, G. J., Surg. Forum., 1996, 47, 237–238.
  • In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin prepara-tions at different pH values. GAN, K. H., GEUS, W. P., BAKKER, W., LAMERS, C. B. H. W., and HEIJERMAN, H. G. M., Aliment Pharmacol. Ther., 1996, 10 (5), 771–775.
  • In vitro and in vivo evaluation of chitosan microspheres containing cisplatin: hepatic artery chemoembolization in dogs. WANG, Y. M., SATO, H., ADACHI, I., Pu, Y. L., ZHU, J. G., ZHOA, Y. LE., and HORIKOSHI, I., Yakuzaigaku, 1996, 56 (3), 140–148.
  • In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells. AKSENTIJEVICH, I., PASTAN, I., LUNARDI, I. Y GALLO, R. C., GorrEsmAN, M. M., and THIERRY, A. R., Hum. Gene Ther., 1996, 7 (9), 1111–1122.
  • In vivo behavior of liposomes modified with a novel galactosyllipid derivative. MURAHASHI, N., and SASAKI, A., Biol. Pharm. Bull., 1996, 19 (3), 418–423.
  • In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography. OKU, N., TOKUDOME, Y., TSUKADA, H., KOSUGI, T., NAMEA, Y., and OKADA, S., Biopharm. Drug Dispos., 1996, 17 (5), 435–4.41.
  • In vivo transfection of rat liver with hepatitis C virus cDNA using cationic liposome-mediated gene delivery. HAYASHI, N., TAKEHARA, T., and KAMADA, T., Proc. Int. Symp. Princess Takamatsu Cancer Res. Fund, 1995, 143–149.
  • In vivo cytokine gene therapy of human tumor xenografts in SOD mice by liposome-mediated DNA delivery. EGILMEZ, N. K., CUENCA, R., YOKOTA, S. J., SORGI, F., and BANKERT, R. B., Gene Ther., 1996, 3 (7), 607–614.
  • In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. TOMITAN, N., MORISHITA, R., HIGAKI, J., TOMITA, S., Amu, M., OGIHARA, T., and KANEDA, Y., Gene Ther., 1996, 3 (6), 477–482.
  • In vitro studies on a new method for Islet microencapsulation using a thermoreversible gelation polymer, N-isopropylacrylamide-based copolymer. Stumm:, S., YAMAZAKI, M., KUBOTA, S., OZASA, T., MORIYA, H., KOBAYASHI, K., MIKAMI, M., MORI, Y., and YAMAGUCHI, S., Artif. Organs, 1996, 20(11), 1232–1237.
  • In-vitro studies of enteric coated diclofenac sodium carboxymethyl cellulose microspheres. ARICA, B., ARICA, M. Y., KAs, H. S., HINCAL, A. A., and HASIRCI, V., J. Microencapsulation, 1996, 13 (6), 689–699.
  • Induction of bovine leukemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. OHISHI, K., KAasyA, H., AMANUMA, H., and ONUMA, M., Vaccine, 1996, 14 (12), 1143–1148.
  • Influence of surfactant-gelatin interaction on microcapsule characteristics. SOVILJ, V., DOKIC, P., SOVILJ, M., and ERDELJAN, A., Prog. Colloid Polym. Sci., 1996, 100, 235–240.
  • Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. BERTHOLD, A., CREMER, K., and KREUTER, J., STP Pharma. Prat., 1996, 6 (5), 358–364.
  • Inhibiting effect of taurine on lipid peroxidation in liposomal membrane. MORIMOTO, Y., TOKUTO/VIE, A., OGAWA, E., FuKusHimA, S., and TAKEUCHI, Y Yakuzaigaku, 1996, 56 (2), 59–64.
  • Injectable biodegradable microspheres for vaccine delivery. KISSEL, T., and KONEBERG, R., Drugs Pharm. Sc., 1996, 77, 51–87.
  • Interaction of synthetic peptide corresponding to signal sequence of glucitol permease of Escherichia cots and its analog with liposomes. WANG, Q., Cul, D., and LIN, Q., Sci. China, Ser C: Life Sci., 1996, 39 (4), 395–405.
  • Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans. NTAN ETTEN, E. W., CHANDRA, H. R., SNIJDERS, S. V., and BAKKER, W. I. A., y. Antimicrob. Chemother., 1995, 36 (6), 961–974.
  • Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. SHINICAI, M., YANASE, M., HONDA, H., WAICABAYASHI, T., YOSHIDA, J., and KOBAYASHI, T., Nni. J. Cancer Res., 1996, 87 (11), 1179–1183.
  • Introduction of human adenomatous polyposis coil gene into Min mice via cationic liposomes. ARENAS, R. B., FICHERA, A., MOK, P., BLANCO, M. C., MICHELASSI, F., Surgery, 1996, 120 (4), 712–717. discussion 717–718.
  • Introduction of silver nano-clusters into poly(vinyl alcohol) core-polystyrene shell type microspheres. SArro, R., OKAMURA, S., and Ishizu, K., Polymer, 1996, 37 (23), 5255–5259.
  • Investigation of in-vitro release characteristics of NSAID-loaded poly(lactic acid) microspheres. Guiziou, B., ARMSTRONG, D. J., ELLIOTT, P. N. C., FORD, J. L., and ROSTRON, C.,.7. Microencapsulation, 1996, 13 (6), 701–708.
  • Iopromide-carrying liposomes as a contrast agent for the liver. KRAUSE, W., LEIKE, J., SCHUHMANN, G. G., SACHSE, A., SCHMIEDL, U., and STRUNK, H., Acad. Radiol., 1996, 3 (Suppl 2), S235–S237.
  • Joint pressure influences synovial tissue blood flow as determined by colored microspheres. HARDY, ARDY., BERTONE, A. L., and MUIR, W. W.J. Appl. Physiol., 1996, 80 (4), 1225-1232. Kinetic stability of liposomes. GROHMANN, F. L., CSEMPESZ, F., and SZOGYI, M., Acta Pharm. Hung., 1996, 66 (5), 197–202.
  • Laser oscillation of a Nd3+-doped fluoride glass microsphere. MIURA, K., TANAKA, K., and HIRAO, K., J. Mater. Sci. Lett., 1996, 15 (21), 1854–1857.
  • Lasing and intermode correlation of whispering Gallery mode in dye-doped polystyrene microspheres. DARWISH, A., CURLEY, M., VENKATESWARLU, P., MOGHBEL, M., MARDI, M., SHARMA, A., and HE, K. X., Proc. SPIE-Int. Soc. Opt. Eng., 1996, 2852, 177–188.
  • Liposomal amphotericin B in the treatment of systemic fungal infection in the neonate. The results of one case. BAQUERO, A. F., SALAS, H. S., and QUERO, J. J., An. Esp. Pediatr., 1996, 45 (2), 209–212.
  • Liposornal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. MOWAT, J. J., Moz, M. J., MACLEOD, B. A., and Madden, T. D., Anesthesiology, 1996, 85 (3), 635–643.
  • Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: hemodynamic changes. SOLTES, S., SHEA, P. N., MUSTARD, R. A., SORIC, I., BOHNEN, J. M., and MITTELMAN, M. W., Shock, 1996, 6 (Suppl 1), S43–S49.
  • Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide. DAE/VIEN, T., Rsurs, J., and SCHERPHOP, G. L., Biochim. Biophys. Acta, 1996, 1285 (2), 219–228.
  • Liposornal amphotericin B (AmBisome): realization of the drug delivery concept. Fop', G., Surfactant Sci. Ser., 1996, 62 (Vesicles), 491–526.
  • Liposomal ATP protects the liver from injury during shock. KoNNo, H., MATIN, A. F., IVIARuo, Y., NAKAMURA, S., and BABA, S., Eur. Surg. Res., 1996, 28 (2), 140–145.
  • Liposornal drug delivery. ALLEN, T. M., Curr. Opin. Colloid Interface Sci., 1996, 1 (5), 645–651. Liposomal formulation of mirfentanil hydrochloride. BETAGERI, G. V., SEGERS, J., SPAULDING, T. C., PEJAVER, S. K., and BitrrrAn4, H. G., PDA J. Pharm. Sci. Technol., 1996, 50 (4), 219–222. Liposomal formulations of cytotoxic drugs. JANKNEGT, R., Support Care Cancer, 1996, 4 (4), 298–304. 31 Refs.
  • Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. GABIZON, A., CHEMLA, M., TZEMACH, D., HOROWITZ, A. T., and GOREN, D.J. Drug Target, 1996, 3 (5), 391–398.
  • Liposome DNA delivery and uptake by cells (review). BouLuoas, Turn., Oncol. Rep., 1996, 3 (6), 989–995.
  • Liposome-based immunosensors. 1. Influence of hapten spacer length on liposome binding efficiency. BAUEMISTER, A. J., KUMMER, T., and SCHMID, R. D., Anal. Lett., 1996, 29 (15), 2601–2613.
  • Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. NAITO, M., NAGAI, H., KAwAxo, S., UMEZU, H., ZHU, H., MORIYAMA, H., YAmAmcrro, T., TAKATsuzA, H., and TAKE, Y., y. Leukoc. Biol., 1996, 60 (3), 337–344.
  • Liposome-mediated NGF gene transfection increases ChAT activity in CNS cell cultures. LE, W., YANG, K., WHITSON, J. S., CLIFTON, G. L., and HAYES, R. L., Neuroreport, 1996, 7 (3), 710–712.
  • Liposome-mediated transfer of genes containing HLA-class II alpha chain into cultured embryonic chick cardiac myocytes and COS7 cells. ALEKSIC, I., REN, M., CZER, L. S., PREMARK, D., DALICHAU, H., BLANCHE, C., TRENTO, A., and BARATH, P., Thorac. Cardiovasc. Surg., 1996, 44 (2), 81–85.
  • Liposome-mediated BDNF cDNA transfer in intact and injured rat brain. lwAmoTo, Y., YANG, K., CLIFTON, G. L., and HAYES, R. L., Neuroreport, 1996, 7 (2), 609–612.
  • Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetric and plasma stability comparison. SKALKO, N., BRANDL, M., BECIREVIC, L. M., FILIPOVIC, G. J., and JALSENJAK, I., Eur. J. Pharm. Sci., 1996, 4 (6), 359–366.
  • Liposomes and lipidic particles in gene therapy. LASIC, D. D., and PEARLMAN, R., Surfactant Sci. Ser., 1996, 62 (Vesicles), 477–489.
  • Liposomes as a vehicle for drug delivery. TAYLOR, K. M., and NEWTON J. M., Br. J. Hosp. Med., 1994, 51(1–2), 55–60. 24 Refs.
  • Liposomes in drug delivery. LASIC, D. G., Surfactant Sci. Ser., 1996, 62 (Vesicles), 447-476. Liposomes in in vivo immunology. CLAASSEN, E., Surfactant Sci. Ser., 1996, 62 (Vesicles), 649-678. Lymphotropic delivery of cyclosporin A by intramuscular injection of biodegradable micro- spheres in mice. YOSHIKAWA, H., and SEEBACH, S., Biol. Pharm. Bull., 1996, 19 (11), 1527–1529.
  • Measurement of regional myocardial blood flow in rats by unlabeled microspheres and Coulter channelyzer. WANG, X., Li, F., SAID, S., CAPASSO, J. M., and GERDES, A. M., Am. J. Physiol., 1996, 271 (4 Pt 2), H1656–H1665.
  • Mechanism of oligonucleotide release from cationic liposomes. ZELPHATI, 0., SZOKA, F. C. J., Proc. Natl. Acad. Sci. USA, 1996, 93(21), 11493–11498.
  • Membrane permeability and stability in buffer and in human serum of fluorinated di-0-alkylglycerophosphocholine-based liposomes. RAVILY, V., SANTAELLA, C., and VIERLING, P., Biochim. Biophys. Acta, 1996, 1285 (1), 79–90.
  • Microencapsulated flavors: manufacture and possible applications. ECKERT, M., Dragoco. Rep: Flavor. Inf. Serv., 1995, (1), 5–19.
  • Microencapsulated genetically engineered E. coil MI5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats. PRAKASH, S., and CHANG, T. M., Artif. Cells Blood Substit. Immobil. Biotechnol., 1996, 24 (3), 201–218.
  • Microencapsulation of mixed fetal pituitary-hypothalamic-nigral cells. WANG, Y., ZHANG, N., Hou, J., and PENG, C., Nanjing Yixueyuan Xuebao, 1996, 16 (4), 324–327.
  • Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. BASIC, D., VACEK, I., and SUN, A. M., Artif. Cells Blood Substit. Immobil. Biotechnol., 1996, 24 (3), 219–255.
  • Micrroencapsulation of drugs by the coacervation technique using ethyl cellulose and acrylate-methacrylate copolymer as wall materials. NIMMANNIT, U., and SUWANPATRA, N., J. Microencapsulation, 1996, 13 (6), 643–649.
  • Microinjection into giant liposomes. Artificial cell studies. OKUMURA, Y., Kagaku (Kyoto), 1996, 51(9), 595.
  • Microsphere embolism-induced changes in presynaptic function of the cerebral cortex in rats. HAYASHI, H., TAKAGI, N., KAMIMOTO, N., and TAKEO, S., Brain Res., 1996, 737 (I, 2), 64–70.
  • Microspheres based detoxification system: a new method in convective blood purification. VON APPEN, K., WEBER, C., LOSERT, U., SCHIMA, H., GURLAND, H. J., and FALKENHAGEN, D., Artif. Organs, 1996, 20 (5), 420–425.
  • Modification of liposomes for liver targeting. Wu, J., and ZERN, M. A., J. Hepatol., 1996, 24 (6), 757–763. 48 Refs.
  • Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages. DE HAAN, A., GROEN, G., PROP. J., VAN ROOIJEN, N., and WILSCHUT, J., Immunology, 1996, 89 (4), 488–493.
  • Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase. IVANOFF, N., PHILLIPS, N., SCHACHT, A. M., HEYDARI, C., CAPRON, A., and RIVEAU, G., Vaccine, 1996, 14(12), 1123–1131.
  • Near-field optical probing of fluorescent microspheres using a photon scanning tunneling microscope. RAHMANI, A., and DE FORNEL, F., Opt. Commun., 1996, 131 (4, 5, 6), 253–259.
  • New drug-delivery system for brain tumor chemotherapy involving thermosensitive, adria-rnycin-releasing liposomes. KAKINUMA, K., TANAICA, R., KATO, M., TAKAHASHI, H., SUDA, T., SAITO, A., and FUJIWARA, H., Drug Delivery Syst., 1996, 11(5), 351–354.
  • New formulation of 5-fluorouracil in microspheres reduces toxicity in mice. HAGIWARA, A., SAICAKURA, C., TSUJIMOTO, H., OHGAKI, M., IMANISHI, T., YAMAZAKI, J., SAWAI, K., TAKAHASHI, T., YAMAMOTO, A., et al., Anti Cancer. Drugs., 1996, 7 (7), 780–784.
  • Nonaqueous dyeing method using dye-containing microcapsules. SHINBO, Y., and SAWANOI, Y Kako Goutsu (Osaka), 1996, 31 (11), 1–5.
  • Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. SUN, Y., MA, X., ZHOU, D., VACEK, I., and SUN, A. M., J. Clin. Invest., 1996, 98 (6), 1417–1422.
  • Novel characteristics of a polystyrene microsphere prepared by microemulsion polymerization. MING, W., ZHAO, J., Lu, X., WANG, C., and Fu, S., Macromolecules, 1996, 29 (24), 7678–7682.
  • Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system. KAsE, R., BIERFREUND, U., KLEIN, A., KOLTER, T., ITOH, K., Suzum, M., HAskilmoTo, Y., SANDHOFF, K., and SAKURABA, H., FEBS Lett., 1996, 393 (I), 74–76.
  • Oral immunization with a model protein entrapped in microspheres prepared from derivatized alpha-amino acids. Hs, S., MIURA, F. J., ZAVALA, F., MURATA, K., LEONE, B. A., and SANTIAGO, N., Vaccine, 1996, 14 (8), 785–791.
  • Oral vaccination by microspheres. BHAGAT, H. R., DALAL, P. S., and NELLORE, R., Drugs Pharm. Sci., 1996, 77, 381–399.
  • Oxygen transporting ability of lipidheme inicrospheres as a totally synthetic red cell substitute. KOMATSU, T., KURONUMA, A., MURAMATSU, Y NISHIDE, H., TSUCHIDA, E., KAKIZAKI, T., and KOBAYASHI, K., Artif. Organs Today, 1996, 5 (3), 207–215.
  • Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. SHARMA, A., SHAsmA, U. S., and STRAUBINGER, R. M., Cancer Lett. (Shannon, Irel), 1996, 107 (2), 265–272.
  • Partial fusion activity of influenza virus toward liposomes and erythrocyte ghosts is distinct from viral inactivation. RAMALHO, S. J., LIMA, M. C., and NIR, S., J. Biol. Chem., 1996, 271 (39), 23902–23906.
  • Passive targeting to solid tumor by long-circulating liposomes. UNEZAKI, S., HOSODA, J., MARUYAMA, K., and IwNrsusu, M., Organ Biol., 1996, 3 (3), 61–68.
  • Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity. KUANG, L., YANG, D. J., INOUE, T., Liu, W. C., WALLACE, S., and WRIGHT, K. C., Anticancer Drugs, 1996, 7 (2), 220–227.
  • Permeability of alginate microcapsules to secretory recombinant gene products. AWREY, D. E., TSE, M., HORTELANO, G., and CHANG, P. L., Biotechnol. Bioeng., 1996, 52 (4), 472–484.
  • pH-dependent microspheres from modified soybean protein hyclrolyzate. MILSTEIN, S. J., BARANTSEVITCH, E. N., GRECHANOVSKI, V. A., and SARUBBI, D. J., y. Microencapsulation, 1996, 13 (6), 651–665.
  • pH-Sensitive liposomes containing a bipolar amphiphile as a protonatable component. JEONG, M. H., LEE, Y. S., JiN, J. Y., and Ko, S. B., Bull. Korean Chem. Soc., 1996, 17 (10), 875-877. Pharmacokinetics and tissue distribution of 5-fluorouracil prodrugs entrapped in liposome. LEE, EE. W., and JEE, U. K., Yakhak Hoechi, 1996, 40 (5), 532–538.
  • Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals. HAGIWARA, A., TAICAHASHI, T., SAWA', K., SAICAKURA, C., TSUJIMOTO, H., IMANISHI, T., OuGANI, M., YAMAZAKI, J., MURANISHI, S., et al., Br. J. Cancer, 1996, 74 (9), 1392-1396. Pharmacological-toxicological expert report Caelyx (Stealth liposomal doxorubicin-HC1). WORKING, P. K., and DAYAN, A. D., Hum. Exp. Toxicol., 1996, 15 (9), 751–785.
  • Phosphatidic acid liposomes as mineralizing surfaces: kinetics and energetics. KRAus, B. L. and CRENSHAW, M. A., Chem. Geol., 1996, 132 (1-4), 183–189.
  • Phospholipid/drug interactions in liposomes studied by rheological properties of monolayers. DOISY, A., PROUST, J. E., IVANOVA, T., PANAIOTOV, I., and DUBOIS, J. L., Langmuir, 1996, 12 (25), 6098–6103.
  • Phospholipids--liposomes—nanoemulsions. IL Effects on skin and product safety. GAREISS, J., Ho, E., and GHYCZY, M., Cosmet. Toiletries, Ed Ital, 1996, 17 (4), 5–6. 8–10.
  • Photodynamic action of hypocrellin A in liposomes. Zou, W., AN, J., Li, B., and JIANG, L., Sci. China, Ser B: Chem., 1996, 39 (5), 477–486.
  • Photolysis of retinol in liposomes and its protection with tocopherol and oxybenzone. YOUNG, A. M., and GREGORIADIS, G., Photochem. Photobiol., 1996, 63 (3), 344–352.
  • Photosensitive microspheres for photoresists. WANG, S. H., and AZUMA, c., J. App. Polym. Sci., 1996, 62 (7), 957–964.
  • Photostability of abamectin/zein microspheres. DEMCHAK, R. J., and DYBAS, R. A., J. Agric. Food Chem., 1997, 45 (1), 260–262.
  • Physical and chemical aspects of liposomes and some of their applications. HIANIR, T., arrovA, L. A., and Ties, H. T., Surfactant Sci. Ser., 1996, 62 (Vesicles), 49–77.
  • Physicochemical characteristics of liposomes formed with internal wool lipids. CODERCH, L., DE LA MAZA, A., PINAZO, A., and PARRA, J. L., j. Am. Oil. Chem. Soc., 1996, 73 (12), 1713–1718.
  • Poly (DL-Iactide) glycolide polymer microsphere entrapped tetanus tozoid: safety evaluation in Wistar rats. CHAUDHURY, M. R., SHARMA, K., and GIRT, D. K., Hum. Exp. Toxicol., 1996, 15 (3), 205–207.
  • Polyacrylate microcapsules for cell delivery. BABENSEEN, J. E., and SErrox, M. V., Drugs Pharm. Sci., 1996, 77, 477–519.
  • Polyanhydride blend microspheres: novel carriers for the controlled release of macromole-cular drugs. THOMAS, P. A., PADMAJA, T., KULKARNI, M. G., y. Controlled Release, 1997, 43 (2, 3), 273–281.
  • Polymer microspheres prepared with a macroinitiator. Part 2. Sugar balls from 2-methacryl-oylozyethyl-d-glucopyranoside. KITANO, H., KAWABATA, J., and MURAMOTO, T., Macrorno/. Chem. Phys., 1996, 197 (11), 3657–3666.
  • Polymerized and microencapsulated liposomes for oral delivery and vaccination. OKADA, J., Drugs Pharm. Sci., 1996, 77, 307–320.
  • Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability. CHEN, H., TORCHILIN, V., and LANGER, R., y. Controlled Release, 1996, 42 (3), 263–272.
  • Polyphosphazene hydrogel microspheres for protein delivery. ANDRIANOV, A. K., and PAYNE, L. G., Drugs Pharm. Sci., 1996, 77, 127–147.
  • Preparation and evaluation of insulin-loaded poly(DL-lactide) microspheres using an experi-mental design. SORIANO, I., EVORA, C., and LLABRES, M., Int. y. Pharm., 1996, 142(2), 135–142.
  • Preparation of 2,3-dicarboxy cellulose microspheres containing antitumor agent as a drug carrier. POPA, M. I., AELENEI, N., and IoNEscu, G., Cellul. Chem. Technol., 1996, 30 (1-2), 33–38.
  • Preparation of poly(DL-lactide) and copoly(lactide-glycolide) microspheres of uniform size. SnicA, K., MURAMATSU, N., and KONDO, T., J. Pharm. Pharmacol., 1996, 48 (9), 891-895. Preparation of metronidazole microcapsules for sustained delivery. EL HELW, A. M., SAKR, F. M., and EL SAYED, G. M., Mansoura. J. Pharm. Sci., 1996, 12 (2), 225–236.
  • Prolongation of liposome circulation time by various derivatives of polyethylene glycols. YUDA, UDA., MARUYAMA, K., and IWATSURU, M., Biol. Pharm. Bull., 1996, 19 (10), 1347-1351. Prolongation of murine cardiac allograft survival by microspheres containing TNF alpha and ILI-beta neutralizing antibodies. GERBER, D. A., °ETTINGER, C. W., D'SOUZA, M., MILTON, G. V., LARSEN, C. P., and PEARSON, T. C., J. Drug Target., 1995, 3 (4), 311–315.
  • Properties of multiphase microspheres of poly(DL-lactic acid) or poly (DL-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion. O'DoNNELL, P. B., and McGitsivrv, J. W., J. Microencapsulation, 1996, 13 (6), 667–677.
  • Protection of a model protein, lactate dehydrogenase by encapsulation in liposome. NEMA, S., and Avis, K. E., PDA J. Pharm. Sci. Technol., 1996, 50 (4), 213–218.
  • Radiative frequency shift and linewidth of an atom dipole in the vicinity of a dielectric microsphere. Kumov, V. V., DUCLOY, M., and LETOKHOV, V. S. J. Mod. Opt., 1996, 43 (11), 2251–2267
  • Rapid high-yield purification and liposome reconstitution of polyhistidine-tagged sensory rhodopsin I. KREBS, M. P., SPUDICH, E. N., and SPUDICH, J. L. Protein Expr. Pun)'., 1995, 6 (6), 780–788.
  • Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. CHENG, P. W., Hum. Gene. Then., 1996, 7 (3), 275–282.
  • Reduction of canine infarct size by bolus intravenous administration of liposomal prosta-glandin El: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin El. FELD, S., LI, G., Wu, A., FELL, P., AMIRIAN, J., VAUGHN, W. K., GORNET, T., SWENSON, C., and SMALLING, R. W., Am. Heart y., 1996, 132 (4), 747–757.
  • Release profiles of recombinant human tumor necrosis factor from Ca2+ -triggering liposome in vivo. YASUI, K., FUJIOKA, H., and NAKAMURA, Y., Biol. Pharm. Bull., 1996, 19(2), 246–251.
  • Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsu-lated dichloromethylene diphosphonate. YAMAMOTO, T., NAITO, M., MORIYAMA, H., UMEZU, H., MATSU°, H., KIWADA, H., and ARAKAWA, M., Am. J. Pathol., 1996, 149 (4), 1271–1286.
  • Resorcinol-formaldehyde and carbon aerogel microspheres. AIN:so, C. T., PERALA, R. W., GROSS, J., Lu, X., CAPS, R., and FRICKE, J., Mater. Res. Soc. Symp. Proc., 1996, 431, 521–525.
  • Ftifampicin carrying poly (DL-lactide)/poly(ethylene glycol) microspheres: loading and release. CELIKKAYA, E., DENKBACS, E. B., and PICSKIN, E., Arts)'. Organs, 1996, 20 (7), 743–751.
  • Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation. SORACE, J. M., ROLLINS, S., ANIAGOLU, J. U., MERGNER, W. J., COLE, K., SWARTZ, G. M. jR., and GREEN, S. J., Pathobiology, 1996, 64 (2), 73–78.
  • Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients. ANDSTROM, E. E., RINGDEN, 0., REMBERGER, M., SVAHN, B. M., and TOLLEMAR, J., Mycoses, 1996, 39 (5-6), 185–193.
  • Sandostatin LAB (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships. Gams, P., MARBACH, P., BRUNS, C., and LANCRANJAN, I., Metabolism, 1996, 45 (8 Suppl 1), 27–30.
  • Simultaneous determination of eight antiepileptic drugs in human serum using a new reversed-phase chromatographic column based on a 2-micrometer porous microsphe-Heal silica gel. TANAKA, E., TERADA, M., MISAWA, S., and WAICASUGL C., jpn. 3. Forensic Toxicol., 1996, 14 (3), 182–190.
  • Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. HARASHIMA, H., HIRAIWA, T., Ocm, Y., and KIWADA, H., 3. Drug Target., 1995, 3 (4), 253–261.
  • Slow delivery of the selective cholecystokinin agonist pBC 264 into the rat nucleus accum-bens using microspheres. BLANCO, P. M. J., DURIEUX, C., DAUGE, V., FATTAL, E., COUVREUR, P., and ROGUES, B. P., 3. Neurochem., 1996, 67 (6), 2417–2424.
  • Sonochemically produced fluorocarbon microspheres: a new class of magnetic resonance imaging agent. WEBB, A. G., WONG, M., KOLBECK, K. J., MAGIN, R., and SUSLICK, K. S., 3. Magn. Reson. Imaging, 1996, 6 (4), 675–683.
  • Specific photoresponse of DMPC liposomes doped with azobenzene derivative around the phase transition temperature. TANAICA, M., SATO, T., and YONEZAWA, Y., Thin Solid Films, 1996, pp. 284–285. 829–832.
  • Specific serological response by active immunization with GD3-bearing liposomes. MAsso, 0., Atm, S. F., LEJARRETA, M., BLASCO, F., and PIULATS, J.,3. Pharmacol. Exp. Ther., 1966, 278 (3), 1114–1120.
  • Spermatozoal microencapsulation and capsule behavior in the female tract. NEBEL, R. L., and SAACKE, R. G., Reprod. Domest. Anim., 1996, 31 (1), 75–85.
  • Stability of proteins and their delivery from biodegradable polymer microspheres. SCHWEN-DEMAN, S. P., CARDAMONS, M., KLIBANOV, A., LANGER, R., and BRANDON, M. R., Drugs Pharm. Sci., 1996, 77, 1–49.
  • Stability of unsaturated soybean lecithin unilamellar liposomes containing vitamin E. BERROCAL, M. C., and ABEGER, A., Acta Technol. Legis. Med., 1995, 6 (3), 543–548.
  • Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. CLELAND, J. L., and JoNEs, A. J. S., Pharm. Res., 1996, 13 (10), 1464–1475.
  • Steady-state and time-resolved fluorescence study of some dyes in polymer microspheres showing morphology dependent resonances. BISHT, P. B., FUKUDA, K., and HIRAYAMA, S., 3. Chem. Phys., 1996, 105 (20), 9349–9361.
  • Sterically stabilized dozorubicin loaded liposomes (DOX-SL): from basics to the clinic. BARENHOLZ, Y., BOLOTIN, E., COHEN, R., and GABIZON, A., Phosphorus, Sulfur. Silicon Relat. Elem., 1996, 109–110 (1–4), 293–296.
  • Stimulation of movement and acrosome reaction of human spermatozoa by PC12 liposomes encapsulating ATP. SKIBA, L. M., AUGER, J., TERRIBILE, J., FATTAL, E., DELATTRE, J., PUISIEUX, F., and JOUANNET, P., Int. 3. Androl., 1995, 18 (6), 287–294.
  • Structural characteristics of cationic liposomes with potent enhancing effect on retroviral transduction into human hepatoma cells. KANEE0, Y., and TsuicamoTo, A., Cancer Lett., 1996, 107 (2), 211–215.
  • Structure and organization of albumin molecules forming the shell of air-filled micro-spheres: evidence for a monolayer of albumin molecules of multiple orientations stabilizing the enclosed air. MYRSET, A. H., NICOLAYSEN, H., Torr, K., CHRISTIANSEN, C., and SKOTLAND, T., Biotechnol. Appl. Biochem., 1996, 24 (Pt 2), 145–153.
  • Studies on gelatin microsphere loaded ligustrazine hydrochloride for lung targeting. ZENG, F., Lu, B., YANG, H., and DENG, X., Yaoxue Xuebao, 1996, 31(2), 132–137.
  • Study on microcapsulated islet heterogenetic transplantation. ZHOU, M., CHEN, D., XIA, Z., YAO, Q., and Znu, H., Zhongguo Yixue Kexueyuan Xuebao, 1996, 18 (3), 204.
  • Subsolubilizing effects of alkyl sulfates on liposomes modeling the stratum corneum lipid composition. DE LA 1VIdtza, A., and PARRA, J. L., Langmuir, 1996, 12 (26), 6218–6223.
  • Surface modifications of liposomes. HIROTA, S., and SADZUKA, Y., Nihon Yukagakkaishi, 1996, 45 (10), 1225–1132.
  • Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats. NEIDHART, M., Experientia, 1996, 52 (9), 892–899.
  • Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl-and N4-hexadecy1-1-beta-D-arabinofuranosylcytosine conjugates. ScHarr, H., and SCHWENDENER, R. A., Anticancer Drug Des., 1996, 11 (6), 451–462.
  • Synthesis and liposome-formation of a thermostable lipid bearing cell adhesion peptide sequence. Hoz), H., Konm, T., YAMAUCHI, K., and KINOSHITA, M., Tetrahedron Lett., 1996, 37 (41), 7391–7394.
  • Targetability of surface-modified albumin microspheres with methotrexate. HWANG, S. J., Jo, H. B., RHEE, G. J., and KIM, C. K., Yakche Hakhoechi, 1996, 26(2), 105–112.
  • Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor. SLEPUSHKIN, V. A., SALEM, I. I., ANDREEV, S. M., DAZIN, P., and DUZGUNECS, N., Biochem. Biophys. Res. Commun., 1996, 227 (3), 827–833.
  • The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrap-ment efficiency and ultracentrifugation damage. HEEREMANS, J. L., GERRITSEN, H. R., MEUSEN, S. P., MUNHEER, F. W., GANGARAM, P. R. S., PREVOST, R., KLUFT, C., and CROMMELIN, D. J., J. Drug Target., 1995, 3 (4), 301–310.
  • The study of arterial infusion chemo-embolization therapy for hepatocellular carcinoma using CDDP-epirubicin-lipiodol multi-complex (CEL) with OK-432-liposome: a pilot clinico-pharmacological study. KATOH, M., ICHIDA, T., SATOH, H., SATOH, K., YAMAGIWA, S., SATOH, Y., ASAKURA, H., and TANNO, K., Drug Delivery Syst., 1996, 11 (5), 355–360.
  • The challenges of recombinant adeno-associated virus manufacturing: alternative use of adeno-associated virus plasmid/liposome complexes for gene therapy applications. LEBKOWSKI, J. S., OKARMA, T. B., and PHILIP, R., Curr. Top Microbiol. Immunol., 1996, 218, 51–59.
  • The effect of adriamycin against a liver metastatic model by encapsulation in liposomes. YACHI, K., SUZUKI, N., TANAKA, N., OKADA, K., MITSUI, I., KAWATO, Y., KOMAGATA, Y., Komn,ANIA, K., and Kncucm, H., Biopharm. Drug. Dispos., 1996, 17 (8), 699–715.
  • The effect of liposome-encapsulated cyprosins on manchego cheese ripening. PicoN, A., SERRANO, C., GAYA, P., MEDINA, M., and NUNEZ, M., J. Dairy Sci., 1996, 79 (10), 1699–1705.
  • The hematopoietic cytokii' te colony stimulating factor 1 is also a growth factor in the CNS: (II): microencapsulated CSF-1 and LM-10 cells as delivery systems. MAYSINGER, D., BEREZOVSKAYA, 0., and FEDOROFF, S., Exp. Neurol., 1996, 141 (1), 47–56.
  • The incorporation and release of bovine serum albumin from poly (hydroxybutyrate-hydroxyvalerate) microcapsules. ATKINS, T. W., and PEACOCK, S. J., J. Microencapsulation, 1996, 13 (6), 709–717.
  • The mechanism of the interaction of ginsenoside-Rbl with liposome dipalmitoyl-phosphatidylcholine. QUAN, W., Wu, X., Bt, Y., Xu, Q., QUAN, Y., Liu, F., BA1, F., TENG, L., LIANG, Y., and Mo, X., Jilin Daxue Ziran Kexue Xuebao, 1996, (2), 49–51.
  • The selective delivery of anticancer agents using target-sensitive liposomes. CHOE, T., Ku, J., JUNG, S., YANG, J., KIM, J., Korean 1. Chem. Eng., 1996, 13 (4), 393–398.
  • The characterization of polyanhydride microspheres. BRUNNER, A., and GOEPFERICH, A., Drugs Pharm. Sci., 1996, 77, 169–202.
  • Thermal analysis of some oxprenolol-loaded bioadhesive microspheres. GHIZDAVU, L., PREDA, M., and LEUCUTA, S. E., Farmacia (Bucharest), 1996, 44 (3-4), 35–40.
  • Tissue cytokine accumulation following administration of liposome-encapsulated hemo-globin in mice. RUDOLPH, A. S., KWASIBORSKI, V., and SPEILBERG, H., Int. Congr. Ser., 1996, 1102, 315–321.
  • TLC characterization of small unilamellar liposomes containing D-myo-inositol derivatives. BRAILOIU, E., BESCHEA, C., BRAILOIU, C., COSTULEANU, A., FILIPEANU, C. M., COSTULEANU, M., FALLGREN, B., and BRANISTEANU, D. D., Biomed. Chromatogr., 1996, 10 (5), 233–236.
  • Transdermal iontophoretic delivery of enkephalin formulated in liposomes. VUTLA, N. B., BETAGERI, G. V., and BANGA, A. K., y. Pharm. Sci., 1996, 85 (1), 5–8.
  • Transepidermal delivery of beta-blocking agents: evaluation of enhancer effects using stratum corneum lipid liposomes. SUHONEN, T. M., PIRSKANEN, L., RAEISAENEN, M., KOSONEN, K., RYTTING, J. H., PARONEN, P., and URTTI, ARTO., J. Controlled Release, 1997, 43 (2, 3), 251–259.
  • Treatment of LPS-induced tissue injury: role of liposomal antioxidants. SUNTRES, Z. E., and SHEK, P. N., Shock, 1996, 6 (Suppl 1), S57–S64.
  • Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. DUEZGUENES, N., FLASHER, D., REDDY, M. V., LUNA, H. J., and GANGADHARAM, P. R. J., Antimicrob. Agents Chemother., 1996, 40(11), 2618–2621.
  • Treatment of massive hemorrhage with liposome encapsulated human hemoglobin (NRC) and hydroxyethyl starch (HFS) in beagles. TAKAORI, M., and Fuxut, A., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1996, 24 (6), 643–653.
  • Triggered release from liposomes mediated by physically and chemically induced phase transitions. GERAS1MOV, 0. V., Rut, Y., and THOMPSON, D. H., Surfactant. Sci. Ser., 1996, 62 (Vesicles), 679–746.
  • Tumor targeting in vivo by means of thermolabile fusogenic liposomes. ZELLMER, S., and CEVC, G., 9. Drug Target., 1996, 4 (1), 19–29.
  • Turbulent and ballistic drag of superfluid helium at low temperatures on an oscillating microsphere. JAEGER, J., and SCHOEPE, W., Czech. 9. Phys., 1996, 46 (Suppl.), 79–80.
  • Ultrasound-triggered delivery of peptides and proteins from microspheres. KOST, J., Drugs Pharm. Sci., 1996, 77, 463–476.
  • Ultrastructural examination of pancreatic islet containing alginate/polyaminoacidic coherent microcapsules. BASTA, G., ROSSODIVITA, M. E., OSTICIOLI, L., LUCA, G., BRUNETTI, P., and CALAFIORE, R., J. Submicrosc. Cytol. Pathol., 1996, 28 (2), 209–213.
  • Ultrastructural studies on microencapsulated oil droplets in aqueous gels and dried films of a new starch-oil composite. Esicnvs, K., FANTA, G. F., FELKER, F., and BAKER, F. L., Carbohydr. Polym., 1996, 29 (3), 233–239.
  • Unsaturated fatty acid-induced increase in liposomal antiexudative activity. BORODULINA, Y. M., and KREINES, V. M., Patol. Fiziol. Eksp. Ter., 1996, (3), 18–20.
  • Validation of a subendocardial ischaemic sheep model by intracoronary fluorescent microspheres. Li, D. S., YoNG, A. C., and KILPATRICK, D., Clin. Exp. Pharmacol. Physiol., 1996, 23 (2), 111–118.
  • Very low threshold whispering-gallery-mode microsphere laser. SANDOGHDAR, V., TREUSSART, F., HARE, J., LEFEVRE, S. V., RAIMOND, J. M., and HAROCHE, S., Phys. Rev. A: At, Mol., Opt. Phys., 1996, 54 (3), R1777–R1780.
  • Zeaxanthin (dihydroxy-8-carotene) but not 8-carotene rigidifies lipid membranes: a 1H-NMR study of carotenoid-egg phosphatidylcholine liposomes. GABRIELSKA, J., and GRUSZECKI, W. I., Biochim. Biophys. Acta, 1996, 1285 (2), 167–174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.